New Jersey Better Educational Savings Trust’s Teva Pharmaceuticals TEVA Stock Holding History

New Jersey Better Educational Savings Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-16,000	Closed	-$946K	–	176
2015 Q2	$946K	Buy	+16,000	New	+$987K	0.61%	56
2015 Q1	–	Sell	-16,000	Closed	-$920K	–	194
2014 Q4	$920K	Sell	16,000 -6,000	-27%	-$334K	0.41%	113
2014 Q3	$1.18M	Buy	+22,000	New	+$1.17M	0.55%	45
2014 Q2	–	Sell	-21,000	Closed	-$1.11M	–	192
2014 Q1	$1.11M	Buy	+21,000	New	+$971K	0.53%	54

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

New Jersey Better Educational Savings Trust's TEVA Position: Q3 2015 in Review

New Jersey Better Educational Savings Trust sold out of Teva Pharmaceuticals (TEVA) in Q3 2015, closing a stake of 16,000 shares — an estimated $946K sold.

New Jersey Better Educational Savings Trust first reported a position in TEVA in Q1 2014 and held it in 4 quarters. The position peaked at $1.18M in Q3 2014. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

New Jersey Better Educational Savings Trust reported no remaining Teva Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
New Jersey Better Educational Savings Trust sold 16,000 Teva Pharmaceuticals shares in Q3 2015, an estimated $946K.
New Jersey Better Educational Savings Trust first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 4 quarters.
New Jersey Better Educational Savings Trust's Teva Pharmaceuticals position peaked at $1.18M in Q3 2014.
823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on New Jersey Better Educational Savings Trust's 13F filing for Q3 2015, filed 2 Nov 2015.